Contineum
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Contineum and other ETFs, options, and stocks.About CTNM
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S.
CTNM Key Statistics
Stock Snapshot
Contineum(CTNM) stock is priced at $14.39, giving the company a market capitalization of 558.87M. It carries a P/E multiple of -6.59.
On 2026-05-06, Contineum(CTNM) stock moved within a range of $13.84 to $14.73. With shares now at $14.39, the stock is trading +4.0% above its intraday low and -2.3% below the session's peak.
Trading volume for Contineum(CTNM) stock has reached 133.18K, versus its average volume of 231.34K.
Over the past 52 weeks, Contineum(CTNM) stock has traded between a high of $16.33 and a low of $3.35.
Over the past 52 weeks, Contineum(CTNM) stock has traded between a high of $16.33 and a low of $3.35.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.